Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Janhavi Bhandari is active.

Publication


Featured researches published by Janhavi Bhandari.


Journal of Biomolecular Screening | 2009

Buffer Optimization of Thermal Melt Assays of Plasmodium Proteins for Detection of Small-Molecule Ligands

Gregory J. Crowther; Alberto J. Napuli; Andrew P. Thomas; Diana J. Chung; Kuzma V. Kovzun; David J. Leibly; Lisa J. Castaneda; Janhavi Bhandari; Christopher J. Damman; Raymond Hui; Wim G. J. Hol; Frederick S. Buckner; Christophe L. M. J. Verlinde; Zhongsheng Zhang; Erkang Fan; Wesley C. Van Voorhis

In the past decade, thermal melt/thermal shift assays have become a common tool for identifying ligands and other factors that stabilize specific proteins. Increased stability is indicated by an increase in the proteins melting temperature (Tm). In optimizing the assays for subsequent screening of compound libraries, it is important to minimize the variability of Tm measurements so as to maximize the assays ability to detect potential ligands. The authors present an investigation of Tm variability in recombinant proteins from Plasmodium parasites. Ligands of Plasmodium proteins are particularly interesting as potential starting points for drugs for malaria, and new drugs are urgently needed. A single standard buffer (100 mM HEPES [pH 7.5], 150 mM NaCl) permitted estimation of Tm for 58 of 61 Plasmodium proteins tested. However, with several proteins, Tm could not be measured with a consistency suitable for high-throughput screening unless alternative protein-specific buffers were employed. The authors conclude that buffer optimization to minimize variability in Tm measurements increases the success of thermal melt screens involving proteins for which a standard buffer is suboptimal. (Journal of Biomolecular Screening 2009:700-707)


Acta Crystallographica Section F-structural Biology and Crystallization Communications | 2011

High-throughput protein production and purification at the Seattle Structural Genomics Center for Infectious Disease

Cassie M. Bryan; Janhavi Bhandari; Alberto J. Napuli; David J. Leibly; Ryan Choi; Angela Kelley; Wesley C. Van Voorhis; Thomas E. Edwards; Lance J. Stewart

An overview of the standard SSGCID protein-purification protocol is given and success rates and cleavage alternatives are discussed.


Analytical Biochemistry | 2010

Use of thermal melt curves to assess the quality of enzyme preparations

Gregory J. Crowther; Panqing He; Philip P. Rodenbough; Andrew P. Thomas; Kuzma V. Kovzun; David J. Leibly; Janhavi Bhandari; Lisa J. Castaneda; Wim G. J. Hol; Michael H. Gelb; Alberto J. Napuli; Wesley C. Van Voorhis

This study sought to determine whether the quality of enzyme preparations can be determined from their melting curves, which may easily be obtained using a fluorescent probe and a standard reverse transcription-polymerase chain reaction (RT-PCR) machine. Thermal melt data on 31 recombinant enzymes from Plasmodium parasites were acquired by incrementally heating them to 90 degrees C and measuring unfolding with a fluorescent dye. Activity assays specific to each enzyme were also performed. Four of the enzymes were denatured to varying degrees with heat and sodium dodecyl sulfate (SDS) prior to the thermal melt and activity assays. In general, melting curve quality was correlated with enzyme activity; enzymes with high-quality curves were found almost uniformly to be active, whereas those with lower quality curves were more varied in their catalytic performance. Inspection of melting curves of bovine xanthine oxidase and Entamoeba histolytica cysteine protease 1 allowed active stocks to be distinguished from inactive stocks, implying that a relationship between melting curve quality and activity persists over a wide range of experimental conditions and species. Our data suggest that melting curves can help to distinguish properly folded proteins from denatured ones and, therefore, may be useful in selecting stocks for further study and in optimizing purification procedures for specific proteins.


Journal of Structural and Functional Genomics | 2011

Leveraging structure determination with fragment screening for infectious disease drug targets: MECP synthase from Burkholderia pseudomallei

Darren W. Begley; Robert C. Hartley; Douglas R. Davies; Thomas E. Edwards; Jess T. Leonard; Jan Abendroth; Courtney A. Burris; Janhavi Bhandari; Peter J. Myler; Bart L. Staker; Lance J. Stewart

As part of the Seattle Structural Genomics Center for Infectious Disease, we seek to enhance structural genomics with ligand-bound structure data which can serve as a blueprint for structure-based drug design. We have adapted fragment-based screening methods to our structural genomics pipeline to generate multiple ligand-bound structures of high priority drug targets from pathogenic organisms. In this study, we report fragment screening methods and structure determination results for 2C-methyl-D-erythritol-2,4-cyclo-diphosphate (MECP) synthase from Burkholderia pseudomallei, the gram-negative bacterium which causes melioidosis. Screening by nuclear magnetic resonance spectroscopy as well as crystal soaking followed by X-ray diffraction led to the identification of several small molecules which bind this enzyme in a critical metabolic pathway. A series of complex structures obtained with screening hits reveal distinct binding pockets and a range of small molecules which form complexes with the target. Additional soaks with these compounds further demonstrate a subset of fragments to only bind the protein when present in specific combinations. This ensemble of fragment-bound complexes illuminates several characteristics of MECP synthase, including a previously unknown binding surface external to the catalytic active site. These ligand-bound structures now serve to guide medicinal chemists and structural biologists in rational design of novel inhibitors for this enzyme.


Acta Crystallographica Section F-structural Biology and Crystallization Communications | 2011

Structures of phosphopantetheine adenylyltransferase from Burkholderia pseudomallei

Thomas E. Edwards; David J. Leibly; Janhavi Bhandari; Jacob B. Statnekov; Isabelle Phan; Shellie H. Dieterich; Jan Abendroth; Bart L. Staker; Wesley C. Van Voorhis; Peter J. Myler; Lance J. Stewart

Phosphopantetheine adenylyltransferase (PPAT) reversibly converts ATP and 4′-phosphopantetheine into dephospho-coenzyme A and pyrophosphate. Crystal structures are presented of PPAT from B. pseudomallei, the pathogenic bacterium that causes melioidosis.


Acta Crystallographica Section F-structural Biology and Crystallization Communications | 2011

BrabA.11339.a: anomalous diffraction and ligand binding guide towards the elucidation of the function of a `putative β-lactamase-like protein' from Brucella melitensis

Jan Abendroth; Banumathi Sankaran; Thomas E. Edwards; Anna S. Gardberg; Shellie H. Dieterich; Janhavi Bhandari; Alberto J. Napuli; Wesley C. Van Voorhis; Bart L. Staker; Peter J. Myler; Lance J. Stewart

The structure of a β-lactamase-like protein from B. melitensis was solved independently using two data sets with anomalous signal. Anomalous Fourier maps could confirm the identity of two metal ions in the active site. AMP-bound and GMP-bound structures provide hints to the possible function of the protein.


Acta Crystallographica Section F-structural Biology and Crystallization Communications | 2011

Structure of fructose bisphosphate aldolase from Bartonella henselae bound to fructose 1,6-bisphosphate

Anna S. Gardberg; Jan Abendroth; Janhavi Bhandari; Banumathi Sankaran; Bart L. Staker

While other aldolases crystallize readily in the apo form, diffraction-quality crystals of B. henselae aldolase could only be obtained in the presence of the native substrate. The quaternary structure is tetrameric, as is typical of aldolases.


Acta Crystallographica Section F-structural Biology and Crystallization Communications | 2011

Structure of fructose bisphosphate aldolase from Encephalitozoon cuniculi.

Anna S. Gardberg; Banumathi Sankaran; Doug Davies; Janhavi Bhandari; Bart L. Staker; Lance J. Stewart

The eukaryotic parasite E. cuniculi expresses a fructose bisphosphate aldolase that crystallizes readily in the presence of the partial substrate analog phosphate. This aldolase–phosphate structure and that of the sugar-bound Schiff base are reported. E. cuniculi aldolase displays a dimeric structure rather than the expected tetrameric quaternary structure.


ACS Medicinal Chemistry Letters | 2010

Discovery of potent and selective inhibitors of CDPK1 from C. parvum and T. gondii

Ryan C. Murphy; Kayode K. Ojo; Eric T. Larson; Alejandro Castellanos-Gonzalez; B. Gayani K. Perera; Katelyn R. Keyloun; Jessica E. Kim; Janhavi Bhandari; Natascha R. Muller; Christophe L. M. J. Verlinde; A. Clinton White; Ethan A. Merritt; Wesley C. Van Voorhis; Dustin J. Maly


Molecular and Biochemical Parasitology | 2011

Identification of inhibitors for putative malaria drug targets among novel antimalarial compounds

Gregory J. Crowther; Alberto J. Napuli; James H. Gilligan; Kerstin Gagaring; Rachel Borboa; Carolyn Francek; Zhong Chen; Eleanor F. Dagostino; Justin B. Stockmyer; Yu Wang; Philip P. Rodenbough; Lisa J. Castaneda; David J. Leibly; Janhavi Bhandari; Michael H. Gelb; Achim Brinker; Ingo H. Engels; Jennifer Taylor; Arnab K. Chatterjee; Pascal Fantauzzi; Richard Glynne; Wesley C. Van Voorhis; Kelli Kuhen

Collaboration


Dive into the Janhavi Bhandari's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Banumathi Sankaran

Lawrence Berkeley National Laboratory

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anna S. Gardberg

Oak Ridge National Laboratory

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge